Peripheral Blood Flow Responses to Electromagnetic Energy
NCT02370199
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Exposure to Man-made Visible Light
Interventions
DEVICE:
670 nm light
DRUG:
octafluropropane
Sponsor
University of Alabama at Birmingham